Predicting solvent and aggregation effects of peptides using group contribution calculations.

Area of Science:

• Biochemistry
• Computational Chemistry
• Neuroscience

Background:

• Amyloid fibril assembly is central to neurodegenerative diseases like Alzheimer's.
• Beta-amyloid peptide aggregation and toxicity are implicated in Alzheimer's disease pathology.
• Soluble beta-amyloid oligomers, not just fibrils, may drive neuronal toxicity.

Purpose of the Study:

• To investigate the predictive power of group contribution methods for designing compounds that modulate beta-amyloid aggregation.
• To correlate calculated activity coefficients with observed effects on solvent surface tension and peptide aggregation.
• To establish a computational approach for the a priori design of aggregation-modulating agents.

Main Methods:

• Utilized group contribution methods to calculate infinite dilution activity coefficients for chemical moieties.
• Analyzed the relationship between calculated activity coefficients and experimental data on solvent surface tension.
• Assessed the correlation between activity coefficients and the impact of compounds on beta-amyloid aggregation.

Main Results:

• Calculated activity coefficients strongly predicted the effect of compounds on solvent surface tension.
• Activity coefficients were also highly predictive of the compounds' influence on beta-amyloid aggregation.
• A significant correlation was observed between compound effects on surface tension and beta-amyloid aggregation.

Conclusions:

• Group contribution calculations offer a reliable method for predicting compound effects on solvent properties.
• This computational approach can guide the rational design of molecules to control peptide aggregation.
• Findings suggest a pathway for developing novel therapeutics for amyloid-related diseases.